Showing the single result
Alpelisib Tablets
FreeProduct Composition & Strength
We supply this product in standardized daily dose packs, designed to achieve the 300 mg daily therapeutic target.
Active Ingredient Strength Primary Clinical Function Alpelisib USP/Ph.Eur. 50 mg / 150 mg The Combination Unit: Used together (150mg x 2) to reach the standard 300mg daily dose. Alpelisib USP/Ph.Eur. 200 mg The Dose-Reduction Unit: Used for patients requiring a lower dose due to side effects (Hyperglycemia/Rash). Excipients Proprietary Matrix Bio-Stable Coating: Engineered to protect the sensitive API and ensure consistent systemic absorption.
